Arima et al. demonstrated that silencing NF1 induced the expression of EMT-TFs in normal human Schwann cells and epithelioid breast cancer cells, suggesting that the loss of neurofibromin expression might activate the EMT-related signaling pathway [54]. This evidence concerns the gene NF1 and breast carcinoma.